Beyond the Warehouse Doors: How MVS Pharma Ensures GDP-Compliant Transportation

Transportation is a critical extension of pharmaceutical distribution activities under the EU Good Distribution Practice (GDP) Guidelines. Once medicinal products leave the warehouse, they remain vulnerable to temperature excursions, physical damage, delays, and unauthorized handling. EU GDP, therefore, requires wholesale distributors to maintain full control over transportation activities, even when these are outsourced. At MVS Pharma GmbH, transportation is managed through structured procedures, qualified service providers, and strong Responsible Person (RP) oversight to ensure product integrity is preserved until delivery.

EU GDP Expectations for Transportation

EU GDP Chapter 9 requires that medicinal products are transported under conditions that maintain their quality, identity, and safety. Distributors must ensure that:

• transport conditions match labeled storage requirements
• vehicles and handling protect products from damage and contamination
• transport service providers are qualified and approved
• deviations and incidents are investigated
• documentation ensures full traceability

Responsibility for GDP compliance during transportation always remains with the distributor.

Transportation Framework at MVS Pharma GmbH

1. Qualified Transport Service Providers

Transportation activities at MVS Pharma GmbH are outsourced to GO Express, a qualified and approved service provider. Selection and approval of transport partners are performed under controlled SOPs and include assessment of:

• GDP capability and experience
• ability to maintain defined transport conditions
• handling procedures and incident management
• documentation and traceability practices

A written service and quality agreement defines GDP responsibilities, escalation procedures, and performance expectations.

• Defined Transport Conditions

Medicinal products are transported in accordance with their labeled storage requirements. Where applicable, products are maintained within 15°C to 25°C during transport. Packaging and vehicle conditions ensure protection against:

• physical damage
• contamination
• environmental exposure
• mix-ups with incompatible goods

Co-transport with food, beverages, or non-compatible materials is strictly prohibited.

Temperature Control and Monitoring During Transport

• Monitoring and Review

Where required, temperature monitoring devices are used during transport to provide objective evidence that products remain within defined limits. Temperature data is reviewed after delivery, and any deviations are documented and assessed.

If a temperature excursion or transport irregularity is identified:

• A deviation is recorded
• The RP evaluates the potential impact on product quality
• Appropriate actions are taken before further distribution

Dispatch and Handover Controls

• Controlled Handover Process

Before dispatch, products undergo a final check to ensure:

• correct product and quantity
• correct batch number and expiry date
• intact packaging
• complete and accurate dispatch documentation

Products are handed over only to authorized transport partners, ensuring continuity of control from warehouse to carrier.

Management of Transport Deviations and Incidents

• Incident Handling and CAPA

Delays, damages, temperature excursions, or any other transport-related incidents are documented and investigated. Root cause analysis is performed, and Corrective and Preventive Actions (CAPAs) are implemented where necessary.

The RP remains actively involved in assessing the impact of transport incidents and determining product disposition.

Training and Awareness

• GDP Awareness Across Transport Activities

Internal personnel involved in dispatch and transport coordination are trained on GDP transportation requirements. Transport partners are informed of MVS Pharma’s expectations regarding handling, communication, and escalation of incidents, reinforcing GDP compliance throughout the transport chain.

Documentation and Traceability

• Record Retention and Oversight

All transport-related documentation, including service agreements, dispatch records, temperature logs, and deviation reports, is retained under the Digital Quality Management System. Records are maintained in accordance with ALCOA+ principles and are readily available for audits and inspections.

Conclusion

MVS Pharma GmbH is committed to maintaining full GDP control over transportation activities beyond its warehouse boundaries. Through qualified transport partners, defined transport conditions, continuous monitoring, structured deviation management, and strong Responsible Person oversight, MVS ensures that medicinal products are delivered safely, compliantly, and without compromise to quality or patient safety.

The post Beyond the Warehouse Doors: How MVS Pharma Ensures GDP-Compliant Transportation appeared first on MVS Pharma.